Table 10.
Comparison of comorbid neuropathology in clinically diagnosed and undiagnosed clinicopathologically defined PSP
| Not PSP (N = 69) | PSP (N = 18) | Total (N = 87) | p-Value | |
|---|---|---|---|---|
| AD, n (%) | 27 (41.5%) | 7 (38.9%) | 34 (41.0%) | 1.000* |
| Braak score, n (%) | 0.032 * | |||
| 0 | 1 (1.4%) | 0 (0.0%) | 1 (1.1%) | |
| 1 | 0 (0.0%) | 1 (5.6%) | 1 (1.1%) | |
| 2 | 3 (4.3%) | 4 (22.2%) | 7 (8.0%) | |
| 3 | 7 (10.1%) | 2 (11.1%) | 9 (10.3%) | |
| 4 | 26 (37.7%) | 2 (11.1%) | 28 (32.2%) | |
| 5 | 28 (40.6%) | 8 (44.4%) | 36 (41.4%) | |
| 6 | 4 (5.8%) | 1 (5.6%) | 5 (5.7%) | |
| PD, n (%) | 14 (21.5%) | 2 (11.1%) | 16 (19.3%) | 0.502* |
| DLB, n (%) | 4 (6.2%) | 0 (0.0%) | 4 (4.8%) | 0.572* |
| VaD, n (%) | 6 (9.2%) | 1 (5.6%) | 7 (8.4%) | 1.000* |
| HS, n (%) | 3 (4.6%) | 1 (5.6%) | 4 (4.8%) | 1.000* |
| AG, n (%) | 30 (46.2%) | 6 (33.3%) | 36 (43.4%) | 0.424* |
*
Fisher Exact p value.